Friday November 27 2009 | Biotechnology feed | All feeds
|
|
VirRx, Inc.
Download detailed PDF Members: VirRx, Inc., is a biotechnology company with a primary interest in cancer gene therapy. Its broad mission is to develop genetically modified "smart bomb" adenoviruses for use in treating human cancers. Adenoviruses are ubiquitous, benign viruses that are one of the causes of the common cold.VirRx scientists are experts on human adenoviruses, including construction of human adenovirus vectors for cancer gene therapy (patent pending).
This page has been viewed 490 times since April 2007, the link to the organisation's website has been followed 71 times Recent Search Terms used to find this page: virrx st louis | VirRx 2009 | virrx | virrx 2009 | . Search for more companies in St. Louis Search for more companies in Missouri This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for VirRx, Inc. | |||||||||||||||||||||||||||||||||||||||||
|